APTASIGN - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79252467
Serial Number
79252467
Registration Number
6160568
Word Mark
APTASIGN
Status
700 - Registered
Status Date
2020-09-29
Filing Date
2018-12-11
Registration Number
6160568
Registration Date
2020-09-29
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2020-07-14
Attorney Name
Law Office Assigned Location Code
N60
Employee Name
BELZER, LYDIA M
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Goods and Services
Medical diagnostic reagents for immunization from disease; diagnostic test reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; reagents for use in medical genetic testing; in vitro diagnostic preparations for medical purposes; clinical diagnostic reagents for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis for medical or veterinary purposes; reagents for use in veterinary genetic testing; antibodies for medical purposes; aptamers for medical purposes; diagnostic antibodies for medical purposes; diagnostic aptamers for medical purposes
Goods and Services
Medical apparatus and instruments, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments other than for dental purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; apparatus for use in medical analysis, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical genetic testing devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical instruments in the nature of genetic fragment analyzers; medical instruments in the nature of genetic material analyzers; medical absorption analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; DNA extraction and purification apparatus for medical purposes; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; body composition analyzers for medical purposes; body fluid analysis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; in vitro diagnostic devices, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical apparatus and instruments for DNA analysis, other than for dental purposes; medical apparatus and instruments for RNA analysis, other than for dental purposes; medical apparatus and instruments for protein analysis, other than for dental purposes; gene and genetic testing apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; cancer diagnosis apparatus, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; diagnostic apparatus for medical purposes, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; medical body composition monitor; medical apparatus and instruments in the fields of clinical diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; immunoassay apparatus for diagnostics, namely, medical devices for measuring, monitoring, sampling, and analyzing nucleotides and proteins, and kits comprised of such medical devices; miniaturized sensors for medical use in gene analysis and diagnosis; veterinary apparatus and instruments for DNA analysis; veterinary apparatus and instruments for RNA analysis; veterinary apparatus and instruments for protein analysis
Goods and Services
Medical and healthcare services relating to DNA and genetics analysis and diagnosis and genetic testing; medical analysis services relating to the treatment of persons; physical examination services; medical services relating to the removal, treatment and processing of human blood, umbilical cord blood, human cells, stem cells and bone marrow; medical analysis for the diagnosis and treatment of persons; RNA or DNA analysis for cancer diagnosis and prognosis; medical analysis services for cancer diagnosis and prognosis; genetic testing for medical purposes; provision of genetic testing for medical treatment purposes; provision of genetic information for medical treatment purposes; medical examination services; rental of medical machines and apparatus; rental of medical apparatus; performing medical diagnostic services involving medical testing and analysis for diagnostic and treatment purposes; medical testing services relating to the diagnosis and treatment of disease; Medical analysis services for the analysis of blood samples for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory; Medical analysis services for the analysis of blood samples taken from patients for diagnostic and treatment purposes provided by a medical laboratory
Pseudo Mark
APT A SIGN
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-02-26
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2019-02-26
Primary Code
010
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-02-26
Primary Code
044
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kisuk Lee
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1451208
International Registration Date
2018-12-11
International Publication Date
2019-02-21
International Renewal Date
2028-12-11
Auto Protection Date
2020-08-21
International Status
001 - Request for extension of protection established
International Status Date
2019-02-21
Priority Claimed In
False
First Refusal In
True
Trademark Events
Event DateEvent Description
2019-02-21SN ASSIGNED FOR SECT 66A APPL FROM IB
2019-02-26NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-03-02APPLICATION FILING RECEIPT MAILED
2019-03-08ASSIGNED TO EXAMINER
2019-03-19NON-FINAL ACTION WRITTEN
2019-03-20NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2019-03-28REFUSAL PROCESSED BY MPU
2019-03-28NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2019-04-12REFUSAL PROCESSED BY IB
2019-07-26TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2019-07-26ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2019-08-13TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-08-13CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-08-14TEAS/EMAIL CORRESPONDENCE ENTERED
2019-09-24EXAMINERS AMENDMENT -WRITTEN
2019-09-24EXAMINERS AMENDMENT E-MAILED
2019-09-24NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2019-09-24ASSIGNED TO LIE
2019-09-25EXAMINER'S AMENDMENT ENTERED
2019-10-17LETTER OF PROTEST EVIDENCE FORWARDED
2019-10-28LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
2020-06-10APPROVED FOR PUB - PRINCIPAL REGISTER
2020-06-24NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-07-14PUBLISHED FOR OPPOSITION
2020-07-14OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-07-22NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
2020-07-22NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2020-08-07NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
2020-09-29REGISTERED-PRINCIPAL REGISTER
2020-12-29FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2021-01-15FINAL DISPOSITION PROCESSED
2021-01-15FINAL DISPOSITION NOTICE SENT TO IB
2021-02-06FINAL DECISION TRANSACTION PROCESSED BY IB